|Industry:||Medical Instruments & Supplies|
|Nephros, Inc. (Nephros) is a medical device company. The Company is engaged in developing and marketing filtration products for therapeutic applications, infection control, and water purification. The Company’s hemodiafiltration (HDF), system is designed for the end-stage renal disease (ESRD), patient. The Nephros HDF system removes a range of harmful substances. As of December 31, 2011, the Company had three products in various stages of development in the HDF modality for ESRD patients and it includes OLpur MDHDF filter series (which it sells in various countries in Europe and consists of its MD190 and MD220 diafilters), OLpur H2H, its add-on module designed to allow the common types of hemodialysis machines to be used for HDF therapy and OLpur NS2000 system, its HDF machine and associated filter technology. Nephros ESRD products are sold and distributed throughout Europe.|
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.